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1. Introduction 
The Hedgehog (Hh) signaling pathway is critical for growth control and patterning during 
embryonic development and adult homeostasis (Jiang and Hui 2008). The identification of 
loss-of-function mutations in PATCHED1 (PTCH1) as the underlying cause of nevoid basal 
cell carcinoma syndrome (Gorlin 2004), which predisposes patients to the development of 
neoplasms including basal cell carcinoma (BCC), first implicated the involvement of the Hh 
pathway in tumorigenesis (Johnson et al., 1996; Hahn et al., 1996). PTCH1 is a Hh-binding 
membrane receptor and functions as a major negative regulator of the pathway by 
inhibiting the signaling membrane protein SMOOTHENED (SMO). Inactivating mutations 
in PTCH1 as well as activating mutations in SMO are commonly found in BCC, and it is 
well established that abnormal Hh pathway activation is the underlying cause of BCC 
(Reifenberger et al., 2005; Ruiz i Altaba, 2006). However, how pathway activation disrupts 
normal skin homeostasis to promote BCC formation remains poorly understood.  
This chapter provides an overview of the Hh pathway and the role of Ptc receptors during 
normal skin homeostasis and tumorigenesis. The Patched mouse model provides an 
excellent tool to study BCC pathogenesis since these mice recapitulate many clinical features 
of human BCC. In addition, the mouse Ptc1 protein is 95% identical to its human 
counterpart PTCH1. Examples of how Patched mouse models have facilitated our 
understanding of the molecular genetic and cellular events of BCC biology will be 
discussed. In particular, we will focus on studies performed to tease out the biological 
function of the C-terminal domain of Ptc and its role not only in tumorigenesis but also stem 
cell biology and cell cycle progression.  
2. Patched: The link between BCC and Hh signaling 
BCC typically arises in sun-exposed skin and is the most commonly diagnosed cancer in the 
Caucasian population, with over one million people diagnosed every year in the United 
States. Despite the high incidence, mortality rate is low, as BCCs rarely metastasize and are 
generally locally invasive. The vast majority of BCCs arise sporadically, although some are 
attributed to a genetic predisposition syndrome. NBCCS (Nevoid basal cell carcinoma 
syndrome, also known as Basal-cell syndrome or Gorlin syndrome, OMIM#109400) is a rare 
autosomal dominant disease in which individuals display a spectrum of developmental 
www.intechopen.com
 
Basal Cell Carcinoma 
 
56
disorders including skeletal malformations, neural tube closure defects, and general 
overgrowth of the body (Gorlin 2004, Gorlin and Goltz 1960). These patients are highly 
susceptible to medulloblastoma (MB) of the cerebellum, rhabdomyosarcoma (RMS) of the 
soft tissue and more frequently BCC.  
A link between BCC and the Hh signaling pathway was discovered in 1996, when two 
independent groups used positional cloning to identify germline mutations in PTCH1 
(9q22.3) in patients with NBCCS and sporadic BCC (Johnson et al., 1996; Hahn et al., 1996). 
This discovery was seminal in understanding the genetic underpinnings of BCC and aided 
researchers in developing a suitable animal model. Transgenic mice that overexpress Sonic 
hedgehog (SHH), the ligand for PTCH1, in the skin develop many features of NBCCS 
including BCC (Oro et al., 1997). In subsequent years, activating mutations in SMO were 
reported in patients with sporadic BCC (Xie et al., 1998). These studies highlight the 
importance and close connection between Hh signaling and BCC biology.  
2.1 Hh signaling in the skin 
Vertebrate Hh signal transduction occurs in the primary cilium, a microtubule-rich 
organelle that protrudes from the cell surface of virtually all mammalian cells (reviewed in 
Goetz and Anderson 2010). Many key components of the Hh pathway are localized to the 
cilium and, in response to Hh stimulus, they dynamically shuttle in or out of this organelle 
(May et al., 2005). In vertebrates, there are three Hh ligands: Sonic hedgehog (Shh), Dessert 
Hh (Dhh) and Indian Hh (Ihh). While Shh is more broadly expressed in tissues, including 
the skin, neural tube and the limb, the action and expression of other ligands are more 
restricted: Dhh in the testis and Ihh in the bone. In the absence of the Hh ligand, Ptc is found 
at the base of the primary cilium and it acts to inhibit the activity of an obligatory 
transmembrane protein Smo, which normally resides in intracellular vesicles (Figure 1). The 
binding of Hh to Ptc promotes its migration out of the cilium, allowing the activation and 
translocation of Smo to the tip. Though the mechanism is unclear, Smo signals downstream 
to generate activator forms of Gli transcription factors that turn on the expression of Hh-
target genes, such as Ptc1 and Gli1 (Figure 1). Mutation in components of the intraflagellar 
transport (IFT) machinery, which is required for cilia production and maintenance, leads to 
patterning defects in Hh-dependent tissues such as the neural tube and the limb (Huangfu 
and Anderson 2005; Liu et al., 2005). Depending on the tissue, loss of IFT function during 
embryogenesis can result in low or high Hh activity as IFTs are required to generate both 
activator and repressor forms of Gli transcription factors (Huangfu and Anderson 2005; Liu 
et al., 2005; May et al., 2005). The dual function of cilia on Hh signaling is also revealed in 
adult tissue homeostasis since removal of cilia could promote as well as suppress Hh-driven 
BCC depending on the oncogenic context (Wong et al., 2009). This action is not tissue-
dependent as it is also observed in other Hh-driven tumors such as MB (Han et al., 2009). 
There are three Gli proteins in the mammalian Hh signaling pathway. Among them, Gli2 is 
the major mediator of Shh signaling during skin development and tumorigenesis (Mill et al., 
2003). Gli2-/- mice display hair follicle growth arrest similar to Shh-/- mutants and 
overexpression of Gli2 drives BCC development and supports tumor growth (Mill et al., 
2003; Hutchin et al., 2005; Grachtchouk et al., 2000). In addition, the level of Gli activity can 
determine tumor type and latency (Huntziker et al., 2006; Grachtchouk et al., 2001). How 
Gli2 is regulated in the skin is unclear, however recent studies have demonstrated that 
www.intechopen.com
 
BCC and the Secret Lives of Patched: Insights from Patched Mouse Models 
 
57 
Suppressor of fused (Sufu) and Kif7 are evolutionarily conserved regulators of Gli 
transcription factors. Sufu, like Ptc, acts as a major negative regulator of the Hh pathway 
and in vitro studies revealed that Sufu inhibits Gli-dependent transcription by anchoring 
Gli2 in the cytoplasm to prevent its access to the nucleus (Humke et al., 2010; Tukachinsky 
et al., 2010). Upon Hh stimulus, Gli dissociates from Sufu and translocates freely to the 
nucleus to activate Hh-target gene transcription (Humke et al., 2010; Tukachinsky et al., 
2010). SUFU mutations have been identified in patients with sporadic BCC; however, these 
are accompanied by additional mutations including PTCH and TRP53 (p53). Therefore, it is 
difficult to determine whether SUFU mutations are the driver or merely passenger 
mutations (Reifenberger et al., 2005). Complete ablation of Sufu in mice leads to embryonic 
lethality and there is conflicting data as to whether Sufu+/- mice are prone to skin tumors 
(Svard et al., 2006; Cooper et al., 2005; Lee et al., 2007). Analysis of Sufu deletion specifically 
in the skin will be useful to resolve this issue. Another regulator of Gli proteins is Kif7, a 
kinesin molecule that acts predominantly as a negative regulator of the Hh pathway 
(Cheung et al., 2009; Liem et al., 2009; Endoh-Yamagami et al., 2009). Kif7 is localized to the 
base of cilia when the pathway is inactive and it translocates to the cilia tip upon pathway 
activation (Endoh-Yamagami et al., 2009; Liem et al., 2009). Upon Hh stimulus, Kif7 is 
required for the accumulation of Gli2 and Gli3 to the cilia tip (Endoh-Yamagami et al., 2009; 
Liem et al., 2009), but the molecular significance of this action has yet to be determined, and 
whether Kif7 plays a role in the skin remains unknown. Since the activity of the Hh pathway 
ultimately culminates on the Gli proteins, studying how molecules regulate Gli2 is critical 
for our understanding of the molecular events of BCC pathogenesis. 
 
Fig. 1. Vertebrate Hh signal transduction. See text for details.  
3. Patched receptors and Patched animal models of BCC 
Human BCCs are difficult to culture and classical mouse models of skin tumors often 
develop other skin tumors and not BCC. This has in many ways hampered efforts to 
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understand BCC pathogenesis. It was not until the generation of the Ptc1+/- mice that BCC 
research truly began to advance. Ptc1+/- mice display many features of NBCCS and develop 
BCC (upon ionizing or ultraviolet (UV) radiation) that has many clinical and histochemical 
features of its human tumor counterparts: slow progression, local invasiveness, and lack of 
metastasis (Aszterbaum et al., 1999; Mancuso et al., 2004). This model facilitated the 
identification of both the genetic events and the molecular basis of BCC. Table 1 outlines the 
current models of BCC using Ptc mutant mice. Next, we will describe how the Ptc1 mutant 
mouse model revealed the temporal importance of proliferation for BCC formation as well 
as gave insight into the genetic control, molecular events and the cell of origin of BCC.  
3.1 The Patched family members: Patched1 and Patched2 
Ptc receptors contain 12 hydrophobic membrane-spanning domains, two large 
hydrophilic extracellular loops as well as intracellular amino- and carboxyl-terminal 
regions (Figure 2). The Ptc receptors have a sterol-sensing domain (SSD) and belong to a 
family of integral-membrane proteins (Kuwabara and Labouesse 2002). SSDs are 
implicated in vesicle trafficking and cholesterol homeostasis. In addition, the predicted 
transmembrane topology of Ptc is similar to the resistance nodulation division (RND) 
family of prototypic bacterial multidrug efflux pumps. RND proteins in bacteria typically 
transport substrates from the cytoplasm to the extracellular space. How Ptc inhibits Smo 
is not well understood but it is not likely through direct physical interactions since Ptc can 
inhibit a large stoichiometric excess of Smo (Taipale et al., 2002). One possibility is that Ptc 
could function as a molecular transporter for a small molecule that directly binds to or 
regulates Smo activity. In agreement with this notion, natural and synthetic molecules can 
modulate the ability of Smo to activate the Hh pathway (Chen et al, 2002).  
 
Fig. 2. Topological models of the mouse Ptc receptors. The two large extracellular loops of Ptc 
receptors bind to the Hh ligands. The CTD of Ptc1 is 273 amino acids in length while the CTD 
of Ptc2 only extends to 71 amino acids (blue). Green denotes the proposed cyclin B1 interacting 
domain of Ptc1 (amino acids 690-779) Amino acids 690-779 of Ptc1 is 51% identical to a similar 
region on Ptc2. Ptc1mes protein retains the first 53 amino acids (blue) of the C-terminal 
cytoplasmic domain and gains a missence mutation of 68 amino acids (red); therefore, lacks 
most of its CTD. Predicated caspase-cleavage site (asterisks). 
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Mutant Type of mutation Phenotype References 
Ptc1+/-  
Loss of function (in-frame 
fusion of lacZ reporter to 
exons 1 and 2) 
Features of NBCCS and increased 
susceptibility to spontanous tumor 
development (RMS and MB) 
Low frequency of spontanous 
trichoblastoma-like tumors 
Enhanced tirchoblastoma-like tumors 
and microscopic BCC-like lesions were 
observed after ultraviolet or ionizing 
radiation 
Goodrich  
et al., 1997; 
Aszterbaum 
et al., 1999;  
Ptc1neo67/+ 
Loss of function (deletion 
of exons 6 and 7) 
Features of NBCCS and increased 
susceptibiilty to spontanous tumor 
development (RMS and MB)  
Non-irradiated mice develop basaloid 
hyperproliferation in the skin 
Irradiated mice develop nodular and 
iniltrative BCC-like tumors 
Hahn  
et al., 1998; 
Mancuso  
et al., 2004 
Ptc1mes/mes 
Deletion of the most C-
terminal cytoplasmic 
domain 
Excess skin; basal cell layer hyperplasia 
and expansion of the epidermal stem 
cell compartment in adult skin 
Makino  
et al., 2001; 
Nieuwenhuis 
et al., 2007 
Ptc1flox/flox Conditional allele 
BCC develops when crossed to skin-
specific promoters of Cre (K6-Cre, K14-
Cre, K5-CrePR1, and Lgr5-CreERT2) 
Adolphe  
et al., 2006 
Villani  
et al., 2010  
Kasper  
et al., 2011 
Ptc1D11 
Weak allele, effect on gene 
and protein product is 
unknown 
Ptc1 homozygous mice are sterile but 
appears normal 
Oro and 
Higgins, 
2003 
PtcB6 
Polymorphism the C-
terminus (T1267N) of Ptc1 
allele found in C57BL/6 
background mice 
compared to FVB/N mice  
C57BL/6 mice are resistant to 
squamouse cell carcinoma induced by 
activated Ras 
Wakabayashi 
et al., 2007 
Ptc2-/- 
Truncated Ptc2 mRNA 
(deletion of exons 5-17), 
effect on protein product is 
unknown 
No discernable skin defect; however, 
Ptc1 and Ptc2 compound mutants have 
increased tumor susceptiblity 
compared to Ptc1 mutants 
Lee  
et al., 2006 
Ptc2tm1/tm1 
Hypomorphic allele 
(disruption of exon 6), with 
several truncated Ptc2 
mRNA products produced, 
effect on protein product is 
unknown  
Male-specific alopecia, ulceration and 
epidermal hyperplasia with 
progressing age 
Nieuwenhuis 
et al., 2006 
Abbreviations: BCC, basal cell carcinoma; NBCCS, nevoid basal cell carcinoma syndrome; MB, 
medulloblastoma; RMS, rhabdomyosarcoma 
Table 1. Summary of Genetic Analyses of Ptc function in the mouse skin. 
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There are two Ptc genes in vertebrates: Ptc1 and Ptc2. PTCH2/Ptc2 encodes a protein with 
45% identity to PTCH1/Ptc1 and contains much shorter intracellular amino- and carboxy-
terminal regions than Ptc1 (Figure 2). They also differ in the hydrophilic loop between 
transmembrane domain 6 (TM6) and TM7. Hh ligands bind to the two extracellular loops of 
PTCH1 and PTCH2 with similar affinity (Carpenter et al., 1998; Marigo et al., 1996). Both 
Ptc1 and Ptc2 inhibit Hh pathway activity in the absence of ligand, however whether this 
inhibition is equivalent has not been determined. PTCH2 mutations were found in some 
cases of sporadic BCC, and a PTCH2 germline mutation was identified in a family with 
NBCCS (Fan et al., 2008; Smyth et al., 1999). This suggests that Ptc2 has a role in 
development and possibly tumor suppression. We found that Ptc2-deficient (Ptc2tm1/tm1) mice 
are viable, fertile and do not develop any obvious developmental defects in Hh-responding 
tissues, such as the hair follicle, limb, neural tube or testis (Nieuwenhuis et al., 2006). 
However, with age, adult male Ptc2tm1/tm1 mice develop epidermal hyperplasia and hair loss. 
Ptc2-deficient mice are not cancer prone but, in the Ptc1+/- background, Ptc2+/- and Ptc2-/- 
mice showed a higher incidence of tumors including BCC when compared to Ptc1+/- mice 
(Lee et al., 2006). These studies demonstrate that Ptc2 is required during adult skin 
homeostasis and possesses overlapping functions with Ptc1 in tumor suppression. The 
divergence of Ptc receptor expression patterns and levels may reflect their unique and 
overlapping roles during embryogenesis and in maintenance of adult tissues such as the 
skin (Carpenter et al., 1998; Motoyama et al., 1998; Nieuwenhuis et al., 2006). 
3.2 Insights gained from Patched animal models  
Ptc1+/- mice in many regards recapitulate the typical pathologies associated with NBCCS, 
including a higher sensitivity to spontaneous tumorigenesis (Aszterbaum et al., 1999; 
Goodrich et al., 1996). The vast majorities of these tumors are MB and RMB, and at a low 
frequency, skin tumors. When these mice are exposed to UV or ionizing radiation, BCC-like 
lesions form, suggesting that additional genetic alterations, possibly caused by DNA 
damage, are required to promote BCC progression. Consistent with this notion, human BCC 
typically occur in sun-exposed areas of the skin and BCC with PTCH1 mutation are 
frequently associated with mutations in p53, a tumor suppressor gene that is mutated in 
over 50% of all human tumors (Ponten et al., 1997; Zhang et al., 2001). Furthermore, BCC 
formation in Ptc1+/- mice was enhanced upon the ablation of p53 in the skin, suggesting that 
Ptc1 mutations synergize with the loss of p53 to promote BCC (Wang et al., 2011). 
Intriguingly, loss of p53 induces the expression of Smo, an obligatory signal transducer of 
the pathway in the interfollicular epidermis (IFE), where Smo expression is normally not 
detected (Wang et al., 2011). How p53 contributes to BCC development is unclear but this 
finding suggests that loss of p53 may promote BCC through its effects on the expression of 
Hh components. Another genetic signature found in BCC is the loss of heterozygosity (LOH) 
at the PTCH1 locus and NBCCS patients with BCC have the remaining somatic wild-type 
PTCH1 allele mutated or deleted (Teh et al., 2005). Similarly, LOH at the Ptc1 locus is observed 
in tumors of Ptc1+/- mice after exposure to UV or ionizing radiation, further illustrating that 
DNA damaging agents are a strong etiological factor in BCC (Aszterbaum et al., 1999). 
Whether inactivation of the second allele of PTCH1 is required for BCC formation could not be 
conclusively addressed using Ptc1+/- models. Using Ptc1 conditional knockout mice, it was 
reported that mice develop BCC only upon biallelic loss of Ptc1 whereas monoallelic 
inactivation of Ptc1 is not sufficient to induce tumorigenesis (Zibat et al., 2009; Kasper et al., 
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2011). These studies have revealed that Ptc1 is a classical tumor suppressor gene and follows 
Knudson’s two hit hypothesis that germline mutation in the PTCH1 locus requires a “second 
hit” for tumorigenesis to occur (Knudson 1996).  
Interestingly, the frequency of BCC and histological BCC subtypes that develop in Ptc1+/- 
mice correlates with the phase of the hair follicle cycle at the time of irradiation. In the adult 
skin, the hair undergoes cyclic nature of active growth (anagen), regression (catagen) and 
rest (telogen) (Figure 3A). Hair follicle keratinocytes at anagen are highly proliferative since 
they are required to generate a new follicle at each hair cycle. Shh pathway activation acts as 
a biological switch for the transition from telogen to anagen. Shh is only detectable during 
anagen and is transcribed asymmetrically in the distal growing tip of the hair follicle, while 
in the IFE, little to no expression of Shh or Hh target genes is detected (Oro and Higgins 
2003). During anagen, Hh target genes are expressed in the hair matrix and dermal papilla 
suggesting that these cells represent Hh-responding cells (Oro and Higgins 2003). As the 
hair degenerates, Ptc1 and Gli1 expression decrease and becomes undetectable at telogen 
(Oro and Higgins 2003). Ptc1+/- mice irradiated at anagen exhibited more advance tumor 
growth and much earlier tumor onset than mice irradiated at telogen (Mancuso et al., 2006). 
This suggests that the hair cycle-induced differences in the proliferation capability of 
keratinocytes can regulate BCC latency and progression.  
Conditional deletion of Ptc1 in the skin has revealed possible molecular events and pathways 
involved in BCC. Inactivation of Ptc1 in the skin induces rapid skin tumor formation without 
disrupting the expression pattern of Notch signaling components and the nucleo-cytoplasmic 
distribution of β-catenin, key signaling molecules known to play a role in the skin (Adolphe et 
al., 2006). Loss of Ptc1 results in the nuclear accumulation of cell cycle regulators cyclin B1 and 
cyclin D1, suggesting that Ptc1 functions as a tumor suppressor in the skin in part through 
regulation of the G1-S and G2-M check points of the cell cycle (Adolphe et al., 2006). 
Consistent with this finding, Ptc1 has been shown to physically interact with cyclin B1, 
tethering it in the cytoplasm (Barnes et al., 2001). The authors tested the clinical significance of 
this interaction by generating a construct that contains a common PTCH1 mutation found in 
NBCCS/BCC patients, which lacks the cyclin B1-binding domain (Barnes et al., 2005). Cell 
culture experiments have shown that Ptc1Q688X, a mutant construct encoding a Ptc1 protein 
truncated at the large intracellular loop, enhances Gli1 activity, promotes proliferation and is 
non-responsive to Shh treatment (Barnes et al., 2005). Since Gli2 has been shown to promote 
the transcription of D-type cyclins, nuclear translocation of cyclin D1 is likely a consequence of 
activated Hh pathway rather than a direct interaction with Ptc1. 
Ptc1 has also been shown to inhibit basal cell progenitor expansion possibly through 
limiting the activity of Insulin-like growth factor binding protein 2 (Igfbp2) (Villani et al, 
2010). The function of Igfbp2 in the skin is unknown; however, there is a positive correlation 
between Igfbp2 expression and human BCC raising the possibility that Igfbp2 is associated 
with BCC (Villani et al, 2010). Whether the control on Igfbp2 activity is a Ptc1-specific 
function or a consequence of activated pathway activity remains unknown. 
The skin is composed of functionally and biologically distinct units: hair follicle, IFE and the 
sebaceous gland (Figure 3B). The basal cell layer in the IFE is continuous with the outer root 
sheath (ORS) of the hair follicle and contains progenitor keratinocytes. Two populations of 
stem cells are required to maintain skin homeostasis: one that resides in the hair follicle 
niche, the bulge and the other dispersed in the IFE (Levy et al., 2005). Genetic lineage 
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analysis demonstrated that bulge cells are capable of generating all lineages of the hair 
follicle to ensure proper tissue homeostasis but only contribute to IFE during wound healing 
(Levy et al., 2007; Ito et al., 2005). Given that the skin is composed of different cell 
populations, a key question that arises is what is the cell of origin of BCC? The development 
of molecular tools was critical to address this question. Using different cell type-specific 
promoters to drive Cre expression to conditionally express an activating mutation in Smo 
(SmoM2), Blainpain’s group elegantly showed that specifically activating Hh signaling in the 
long-lived K14+ progenitors of the IFE induces BCC formation (Youssef et al., 2010). In 
contrast, K15+ cell fate mapping analysis on irradiated Ptc+/- model of BCC revealed that the 
majority of BCC arose from K15 expressing hair follicle bulge stem cells (Wang et al., 2011). 
These studies would suggest that both hair follicle stem cells (K15+) and epidermal progenitor 
cells (K14+) are capable of tumor-initiation and that epidermal cell subpopulations are 
sensitive to different Hh-driven BCC mutations. Interestingly, cutaneous injury has been 
shown to influence the cell of origin of BCC. For example, overexpression of SmoM2 in the 
K15+ bulge cells does not lead to BCC; however, wounding can induce migration of oncogene-
expressing bulge cells to the sites of injury to promote BCC formation (Wong and Reiter 2011). 
Taken together, these studies illustrate that the cell of origin of BCC is context dependent, 
encompassing both the type of activating mutations and factors involved in wound healing.  
 
Fig. 3. Adult hair cycle. In the adult skin, the hair follicle constantly degenerates (catagen), 
rests (telogen) and grows (anagen). Only the non-permanent region of the hair follicle, 
below the bulge stem cells (SC) participates in these phases of hair cycle. Bulge SCs are 
located beneath the sebaceous gland (SG). Following telogen, when the dermal papilla (DP) 
is proximal to the permanent follicle segment, the bulge SC are activated (red arrows) to 
initiate a new round of hair growth by producing transiently amplifying cells/matrix cells 
(Mx). The matrix cells will give rise to all differentiated layers of the mature hair follicle.  
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4. C-terminal domain of Ptc1: Cell survival, cell cycle progression and stem 
cell maintenance in the epidermis 
Besides its ability to inhibit Hh signaling, Ptc1 has been shown to act as a dependence receptor. 
Dependence receptors promote cell survival when bound to their ligands and induce 
programmed cell death in the absence of the ligand. Overexpression of Ptc1 results in 
apoptosis in both cell culture and the neural tube of chick embryos and this can be reversed 
through addition of Shh ligand (Thibert et al., 2003). The ability of Ptc1 to induce cell death is 
dependent on a caspase-cleavage site located at Asp 1392, 42 amino acids from the C-terminus 
of Ptc1 (Figure 2) (Thibert et al., 2003; Mille et al., 2009). Interestingly, Ptc-induced cell death is 
not affected through expression of Smo, suggesting that Ptc’s ability to induce apoptosis is 
independent of Ptc-Smo transduction. How Ptc transduces this survival signal downstream 
and whether this is dependent on the Gli transcription factors are unknown.  
Interestingly, the majority of PTCH1 mutations identified in BCC result in premature 
truncation of the protein (Daya-Grosjean and Couve-Privat 2005). These findings raise the 
tantalizing possibility that the C-terminal half of PTCH1 is crucial for tumor suppression. 
Little is known about the C-terminal domain (CTD) of Ptc1 in the context of skin 
development and homeostasis. Our group aimed to address these questions by analyzing 
Ptc1mes mice. A spontaneous recessive mutation in Ptc1, mesenchymal dysplasia (mes) was 
found in mice containing a missense mutation resulting in a 32bp deletion and a 152 amino 
acid truncation of the CTD (Figure 2) (Sweet et al., 1996; Makino et al., 2001). It was reported 
that Ptc1mes/mes mice possess excess skin, suggesting that the CTD of Ptc1 is involved in skin 
development and/or homeostasis (Makino et al., 2001). We found that adult Ptc1mes/mes mice 
have severe epidermal hyperplasia starting as early as postnatal day 12. These mice 
displayed hyperproliferation of the basal cell population, attributed to increased c-Myc 
expression, while stratification and apoptosis of the epidermis were not affected. Despite the 
fact that Ptc1 is a major negative regulator of Hh signaling, Ptc1mes/mes mice displayed normal 
pathway activity in the epidermis, and the Ptc1mes protein maintained similar Shh-binding 
abilities to wild-type Ptc1. These data suggest that the function of the CTD is independent of 
Shh pathway/Gli activity. Normally, epidermal stem cells rarely divide and reside in two 
functionally distinct locations in the skin: the bulge and the IFE. Using BrdU pulse-chase 
labeling, we found that Ptc1mes/mes epidermis exhibited an increase in the number of label-
retaining cells (i.e. quiescent stem cells) in the IFE, indicating that the CTD is required for 
epidermal stem cell maintenance (Figure 4). Despite the persistent hyperplasia phenotype, 
Ptc1mes/mes mice do not develop skin tumors even in response to the DNA damaging effects of 
radiation (unpublished data). It has been reported that the level of Hh pathway activity 
determines tumor outcome, ranging from epidermal hyperplasia to BCCs. Therefore we 
speculate that the lack of tumorigenesis may be attributed to normal Hh pathway activity 
observed in Ptc1mes/mes adult mice. As wounding can contribute to tumor outcome, it 
would be interesting to determine whether injury can promote tumorigenesis in the mes 
background. Given that Ptc1+/- mice are more susceptible to tumorigenesis, whether the 
mes mutation can modulate tumorigenesis of Ptc1+/- mice remains to be determined. 
Together, our study revealed a novel, unexpected role for the CTD of Ptc1 in the 
regulation of epidermal homeostasis. Furthermore, it highlights a non-canonical function 
of Ptc1, which appears to be independent of Gli activity.  
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Fig. 4. Ptc1mes/mes epidermis exhibits an increase in the number of label-retaining cells. (A) 
Schematic diagram illustrating pulse-chase experiment. Ten-day-old wild-type and 
Ptc1mes/mes pups received four consecutive BrdU injections at 12-hour intervals to label all 
mitotic cells. Skin samples were collected 30 and 80 days post-labeling (dpl). (B–E) Basal 
cells were identified using K-14/BrdU double labelling and are considered to be label-
retaining interfollicular epidermal stem cells (B, D, E; arrowheads). Suprabasal cells were 
identified using K-10/BrdU double labeling. These cells were not considered to be 
interfollicular stem cells and were not counted (C; arrowhead). (D, E) BrdU/K-14-double 
positive cells could be detected at 30 (D) and 80 (E) dpl in wild-type and Ptc1mes/mes skin. (F) 
At 30 days, skin showed a 3.6-fold increase in BrdU/K14-double positive cells. A 3.3-fold 
increase was observed at 80 dpl. Data represent the mean ± SEM. Scale bars = 50 μm. 
Reprinted from Developmental Biology, E.N., P.C.B., S.M., C.-c. H., Epidermal hyperplasia 
and expansion of the interfollicular stem cell compartment in mutant mice with C-terminal 
truncation of Patched1, 308, 547-560, © 2007, with permission from Elsevier. 
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5. Conclusion and future prospective 
The establishment of Ptc mutant mouse models of BCC has given us critical insight into the 
genetic underpinnings and the molecular events that drive BCC formation. We described 
here that the tumor suppressor Ptc1 is a multifaceted protein that is not solely dedicated to 
repressing the Hh pathway. By attempting to understand BCC biology using the Ptc1 mouse 
model, researchers have serendipitously stumbled upon the non-canonical functions of Ptc1. 
In the neural tube, Shh can act as a chemical cue to guide commissural axons independent of 
Gli transcription factors, further illustrating that Gli activity is not always coupled to the 
Shh-Ptc module (Okada et al., 2006; Yam et al., 2009). Interestingly, the non-canonical 
actions of Ptc1 can be traced to its C-terminal domain, which is largely absent in Ptc2, 
suggesting a functional divergence between the Ptc family of receptors.  
Our group found that the CTD of Ptc1 is important in stem cell homeostasis of the IFE, 
identifying Ptc1 as a pivotal switch between quiescence or cell cycle progression 
(Nieuwenhuis et al., 2007). The molecular events mediating this outcome remain unclear. 
We speculate that the CTD of Ptc1 might act as a docking site for regulatory proteins 
required for stem cell maintenance. Determining these potential binding partners could 
help decipher the atypical functions of Ptc1. Mutations of the PTCH1 locus in BCC 
typically display a truncating mutation in one allele and a deletion on the other (Reichrath 
2006). Further analyses on the monoallelic loss of Ptc1 in conjunction with Ptc1 point 
mutations will be necessary to recapitulate the molecular events leading to BCC 
pathogenesis, which cannot be uncovered using current Ptc mouse models.  
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